The program's research activities are reflected in the making of new scientific discoveries in gynecologic pathology and receiving several program grant awards from the National Institutes of Health's Cervical Cancer SPORE, the National Cancer Institute's Specialized Ovarian Cancer Research, the Department of Defense Ovarian Cancer Consortium, the Break Through Cancer Project and the NIH/NCI U2C Early Detection Network study, in addition to individual research awards. This program has supported the Johns Hopkins Gynecologic Tumor Bank for more than a decade.
Our strong commitment to continuing the legacy of Dr. TeLinde is evident in our basic science and translational research, which focuses on ovarian, uterine, and cervical cancers, as well as gestational trophoblastic diseases (tumors arising in the placental cells during the early stages of pregnancy) and endometriosis.